Influence of cigarette smoking on rate of reopening of the infarct-related coronary artery after myocardial infarction: A multivariate analysis

Journal of the American College of Cardiology

Volumn 27, Issue 7, 1996, Pages 1662-1668

  De Chillou, Christian ^a   Riff, Pascal ^a   Sadoul, Nicolas ^a   Éthevenot, Gérard ^a   Feldmann, Luc ^a   Isaaz, Karl ^a   Simon, Jean Philippe ^a   Boursier, Michel ^b   Khalifé, Khalifé ^b   Thisse, Jean Yves ^c   Aliot, Etienne ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b Centre Hospitalier Ré gional   (France)

^c Hôpital Central ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CIGARETTE SMOKING; CORONARY ARTERY DILATATION; CORONARY RISK; DIABETES MELLITUS; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING CESSATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLASMINOGEN ACTIVATORS; RECURRENCE; RISK FACTORS; SMOKING; STREPTOKINASE; STROKE VOLUME; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT FAILURE; VASCULAR PATENCY;

EID: 0029887136     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(96)00091-5     Document Type: Article

References (33)

1. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Lancet 1987;2:871-4.
2. Second International Study of Infarct Survival (ISIS II). Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction. Lancet 1988;2:349-60.
3. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Lancet 1988;2:525-30.
4. APSAC Intervention Mortality Study (AIMS). Effect of intravenous APSAC on mortality after myocardial infarction: preliminary report of a placebo-controlled clinical trial. Lancet 1988;2:545-9.
5. Thrombolysis in Myocardial Infarction Trial, Phase I (TIMI). A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Circulation 1987;76:142-54.
6. Intravenous Streptokinase in Acute Myocardial Infarction (ISAM). A prospective trial of intravenous streptokinase in acute myocardial infarction. N Engl J Med 1986;314:1465-71.
7. European Cooperative Study Group (ECSG). Intravenous tissue plasminogen activator and infarct size, left ventricular function, and survival in acute myocardial infarction. BMJ 1988;297:1374-9.
8. DeWood MA, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980;303:897-902.
9. Rentrop KP, Blanke H, Karsch KR. Acute myocardial infarction: intracoronary application of nitroglycerin and streptokinase. Clin Cardiol 1979;2:354-63.
10. Granger CB. Thrombolytic therapy. In: Topol EJ, Serruys PW, editors. Current Review of Interventional Cardiology. Philadelphia: Current Medicine, 1994:5.1-5.16.
11. Pekkanen J, Linn S, Heiss G, et al. Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N Engl J Med 1990;322:1700-7.
12. Holmes DR Jr, Davis KB, Mock MB, et al, and participants in the Coronary Artery Surgery Study. The effect of medical and surgical treatment on subsequent sudden cardiac death in patients with coronary artery disease: a report from the Coronary Artery Surgery Study. Circulation 1986;73:1254-63.
13. Meade TW, Imeson J, Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischemic heart disease. Lancet 1987;2:986-8.
14. Kannel W, D'Agostino RB, Belanger AJ. Fibrinogen, cigarette smoking and risk of cardiovascular disease: insights from the Framingham study. Am Heart J 1987;113:1006-10.
15. Fitzgerald GA, Oates JA, Nowak J. Cigarette smoking and hemostatic function. Am Heart J 1988;115:267-71.
16. Folts JD, Bonebrake FC. The effects of cigarette smoke and nicotine on platelet thrombus formation in stenosed dog coronary arteries: inhibition with phentolamine. Circulation 1982;65:465-70.
17. Meade TW, Vickers MV, Thompson SG, Stirling Y, Haines AP, Miller GJ. Epidemiologic characteristics of platelet aggregability. BMJ 1985;290:428-32.
18. McGill HC Jr. The cardiovascular pathology of smoking. Am Heart J 1988;115:250-7.
19. Wilhelmsen L, Svardsudd K, Korsan-Bengsten K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke or myocardial infarction. N Engl J Med 1984;311:501-5.
20. Mueller HS, Cohen LS, Braunwald E, et al, for the TIMI investigators. Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the thrombolysis in myocardial infarction (TIMI) trial, phase II. Circulation 1992;85: 1254-64.
21. Barbash GI, White HD, Modan M, et al, for the investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality trial. Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality trial. Circulation 1993;87: 53-8.
22. Rivers JT, White HD, Cross DB, Williams BF, Norris RM. Reinfarction after thrombolytic therapy for acute myocardial infarction followed by conservative management: incidence and effect of smoking. J Am Coll Cardiol 1990;16:340-8.
23. Gomez MA, Karagounis LA, Allen A, Anderson JL, for the TEAM-2 investigators. Effect of cigarette smoking on coronary patency after thrombolytic therapy for myocardial infarction. Am J Cardiol 1993;72:373-8.
24. Anderson JL, Sorenson SG, Moreno F, et al, and the TEAM-2 study investigators. Multicenter patency trial of intravenous anistreplase compared with streptokinase in acute myocardial infarction. Circulation 1991;83:126-40.
25. Tendera MP, Campbell WB, Tennant SN, Ray WA. Factors influencing probability of reperfusion with intracoronary ostial infusion of thrombolytic agent in patients with acute myocardial infarction. Circulation 1985;71: 124-8.
26. Bates ER, Califf RM, Stack RS, et al, and the Thrombolysis and Angioplasty in Myocardial Infarction Study Group. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI-I) trial: influence of infarct location on arterial patency, left ventricular function and mortality. J Am Coll Cardiol 1989;13:12-8.
27. Rosenberg L, Kaufman DW, Helmrich SP, Shapiro S. The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med 1985;313:1511-5.
28. Hermanson B, Omenn GS, Kronmal RA, Gersch BJ, and participants in the Coronary Artery Surgery Study. Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease. N Engl J Med 1988;319:1365-9.
29. Rosenberg L, Palmer JR, Shapiro S. Decline in the risk of myocardial infarction among women who stop smoking. N Engl J Med 1990;322:213-7.
30. U.S. Department of Health and Human Services. Preventing tobacco use among young people: a report of the Surgeon General. Atlanta: U.S. Department of Health and Human Services, Public Health Service, Center for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 1994.
31. Karagounis L, Sorensen SG, Menlove RL, Moreno F, Anderson JL Does Thrombolysis in Myocardial Infarction (TIMI) perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 study. J Am Coll Cardiol 1992;19: 1-10.
32. Vogt A, von Essen R, Tebbe U, Feuerer W, Appel KF, Neuhaus KL. Impact of early perfusion status of the infarct-related artery after thrombolysis for acute myocardial infarction on short-term mortality: a retrospective analysis of four German multicenter studies. J Am Coll Cardiol 1993;21:1391-5.
33. Grines CL, Topol EJ, O'Neill WW, et al. Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation 1995;91:298-303.